EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 10, Pages 504
Publisher
MDPI AG
Online
2019-10-01
DOI
10.3390/pharmaceutics11100504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of sterol derivatives on properties of soybean and egg yolk lecithin liposomes: Stability, structure and membrane characteristics
- (2018) Kedong Tai et al. FOOD RESEARCH INTERNATIONAL
- Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
- (2018) Muhammad Riaz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin
- (2018) Lili Zou et al. BIOMATERIALS
- Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
- (2018) Esben Christensen et al. International Journal of Nanomedicine
- RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics
- (2018) Yu Cheng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Role of freeze-drying in the presence of mannitol on the echogenicity of echogenic liposomes
- (2017) Krishna N. Kumar et al. JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
- Characterization of Pegylated Liposomal Mitomycin C Lipid-Based Prodrug (Promitil) by High Sensitivity Differential Scanning Calorimetry and Cryogenic Transmission Electron Microscopy
- (2017) Xiaohui Wei et al. MOLECULAR PHARMACEUTICS
- Targeting cholesterol transport in circulating melanoma cells to inhibit metastasis
- (2017) Yu-Chi Chen et al. Pigment Cell & Melanoma Research
- Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging
- (2017) May Lin Yap et al. Theranostics
- A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers
- (2016) Deo R. Singh et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications
- (2016) Anisha A. D’souza et al. Expert Opinion on Drug Delivery
- EphA2 is a functional receptor for the growth factor progranulin
- (2016) Thomas Neill et al. JOURNAL OF CELL BIOLOGY
- Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer
- (2016) Ketan Patel et al. MOLECULAR PHARMACEUTICS
- Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer
- (2016) Ketan Patel et al. Nanomedicine
- Tumor cell vascular mimicry: Novel targeting opportunity in melanoma
- (2016) Mary J.C. Hendrix et al. PHARMACOLOGY & THERAPEUTICS
- New Developments in Liposomal Drug Delivery
- (2015) Bhushan S. Pattni et al. CHEMICAL REVIEWS
- Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells
- (2015) Bainan Wu et al. CHEMISTRY & BIOLOGY
- Design of liposomal formulations for cell targeting
- (2015) Eugénia Nogueira et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity
- (2015) K E Duncan et al. EYE
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
- (2015) Sarah J. Welsh et al. Therapeutic Advances in Medical Oncology
- Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Incorporating Fatty Acid-Modified Polyethylenimine
- (2014) Zhihua Guo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Nanopharmaceuticals (part 1): products on the market
- (2014) Volkmar Weissig et al. International Journal of Nanomedicine
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
- (2014) B. Miao et al. Cancer Discovery
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Ligation Strategies for Targeting Liposomal Nanocarriers
- (2014) Patricia Marqués-Gallego et al. Biomed Research International
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Mechanism of Protein Stabilization by Trehalose During Freeze-Drying Analyzed by In Situ Micro-Raman Spectroscopy
- (2013) Alain Hedoux et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Preparation, characterization, and moisturizing effect of liposomes containing glucosamine and N-acetyl glucosamine
- (2013) Bizhan Malaekeh-Nikouei et al. Journal of Cosmetic Dermatology
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
- (2012) Si Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stabilization of liposomes during drying
- (2011) Pall Thor Ingvarsson et al. Expert Opinion on Drug Delivery
- Epha2 is a critical oncogene in melanoma
- (2011) D Udayakumar et al. ONCOGENE
- Emerging strategies for EphA2 receptor targeting for cancer therapeutics
- (2010) Manish Tandon et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting
- (2010) Ngoc Trinh Huynh et al. Nanomedicine
- Nanoparticle-based targeted drug delivery
- (2009) Rajesh Singh et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- An overview of liposome lyophilization and its future potential
- (2009) Chengjun Chen et al. JOURNAL OF CONTROLLED RELEASE
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM)
- (2008) Lijuan Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started